+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Continuous Bioprocessing Market by Product Type (Cell Therapies, Gene Therapies, Monoclonal Antibodies), Process Stage (Downstream Bioprocessing, Upstream Bioprocessing), Technology, Bioreactor Type, End User, Scale Of Production - Global Forecast 2025-2030- Product Image
Continuous Bioprocessing Market by Product Type (Cell Therapies, Gene Therapies, Monoclonal Antibodies), Process Stage (Downstream Bioprocessing, Upstream Bioprocessing), Technology, Bioreactor Type, End User, Scale Of Production - Global Forecast 2025-2030- Product Image
Sale

Continuous Bioprocessing Market by Product Type (Cell Therapies, Gene Therapies, Monoclonal Antibodies), Process Stage (Downstream Bioprocessing, Upstream Bioprocessing), Technology, Bioreactor Type, End User, Scale Of Production - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5012940
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The continuous bioprocessing market is reshaping the future of biopharmaceutical manufacturing, enabling organizations to achieve operational efficiency, supply security, and robust quality outcomes in an increasingly competitive and regulated environment. Senior leaders have an opportunity to leverage this transformative platform to streamline production, accelerate innovation, and align with evolving global demands.

Market Snapshot: Continuous Bioprocessing Market Growth Overview

The Continuous Bioprocessing Market grew from USD 282.42 million in 2024 to USD 343.95 million in 2025, and is projected to expand at a CAGR of 21.40%, reaching USD 904.20 million by 2030. This robust trajectory reflects a fundamental industry pivot towards uninterrupted processing, improved scalability, and real-time monitoring. Dynamic investments, technology integration, and regulatory shifts are rapidly driving market expansion. As production footprints evolve, organizations are seeking agile models that minimize variability and resource usage while delivering consistent product quality across global supply chains.

Scope & Segmentation of the Continuous Bioprocessing Market

  • Product Types:
    • Cell therapies, including CAR-T and stem cell treatments
    • Gene therapies (viral vector and non-viral approaches)
    • Monoclonal antibodies
    • Recombinant proteins such as enzymes, growth factors, insulin
    • Vaccines, both conventional and mRNA-based
  • Process Stages:
    • Upstream bioprocessing (continuous cell culture, perfusion culture)
    • Downstream bioprocessing (chromatography, extraction, filtration)
  • Technologies:
    • Continuous chromatography systems
    • Continuous filtration systems
    • Perfusion systems
    • Single use systems
  • Bioreactor Types:
    • Single use bioreactors
    • Stainless steel bioreactors
  • End Users:
    • Large and small biotech firms
    • Contract development and manufacturing organizations
    • Pharmaceutical companies (big pharma and mid-tier)
    • Research institutes
  • Scale of Production:
    • Commercial large, medium, and small facilities
    • Laboratory reactors (less than and within 50-200L)
    • Pilot plant scales (below 200L, 200-500L, and above 500L)
  • Regions:
    • Americas (including the United States, Canada, and Latin American countries)
    • Europe, Middle East, and Africa (various national markets)
    • Asia-Pacific (with active markets across East and Southeast Asia)
  • Leading Companies:
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Sartorius AG
    • Lonza Group AG
    • FUJIFILM Diosynth Biotechnologies
    • Repligen Corporation
    • Novasep Holding SAS
    • Applikon Biotechnology B.V.
    • Parker Hannifin Corporation

Key Takeaways for Senior Decision-Makers

  • Continuous bioprocessing integrates upstream and downstream steps into seamless operations, streamlining production and supporting compliance with modern manufacturing standards.
  • Digital transformation enables predictive process control, reducing variability and allowing organizations to mitigate risks before they impact yield or quality.
  • Single use technologies and modular bioreactor systems foster agility and facilitate product changeovers, especially crucial in multiproduct facilities.
  • Strategic supply chain diversification and local partnerships help manufacturers address geopolitical uncertainties and complex trade requirements.
  • Collaboration with regulatory agencies remains vital; proactive engagement can accelerate approval timelines and integration of continuous modalities.
  • Workforce upskilling, especially in digital literacy and process optimization, ensures teams can operate advanced continuous bioprocessing platforms efficiently.

Tariff Impact on Continuous Bioprocessing Supply Chains

Recent U.S. tariff changes have increased procurement and equipment costs, prompting companies to diversify sourcing, reassess just-in-time strategies, and invest in domestic production capabilities. These pressures highlight the importance of resilient supplier networks and agile inventory practices.

Methodology & Data Sources

This analysis is grounded in in-depth interviews with industry executives, engineers, and regulatory authorities, supported by secondary data from peer-reviewed research, trade data, and market presentations. A triangulation approach aligns qualitative insights with quantitative evidence for accurate, actionable conclusions.

Why This Report Matters

  • Provides a holistic understanding of the fast-evolving continuous bioprocessing market, including key segment opportunities and technological advancements.
  • Enables informed strategy development around supply chain resilience, regulatory compliance, and technology adoption for sustained competitive advantage.
  • Equips executives with critical knowledge to shape investments, operations, and workforce capability planning for future-ready manufacturing.

Conclusion

Continuous bioprocessing is enabling the next generation of agile, sustainable manufacturing in biopharma. Companies embracing these innovations will elevate operational excellence and secure long-term market resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of real-time analytics and AI-driven control to optimize continuous bioprocesses across scales
5.2. Development of single-use perfusion bioreactor platforms enabling high-density cell culture in continuous mode
5.3. Implementation of continuous multi-column chromatography to enhance downstream purification efficiency
5.4. Regulatory frameworks evolving to provide guidance on real-time release testing for continuous biomanufacturing
5.5. Adoption of digital twin modeling for predictive troubleshooting and scale-up of continuous bioprocess systems
5.6. Advancements in continuous viral vector production processes to meet growing demand for gene therapies
5.7. Integration of closed automation systems to reduce contamination risk and improve process reproducibility
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Continuous Bioprocessing Market, by Product Type
8.1. Introduction
8.2. Cell Therapies
8.2.1. Car-T Therapies
8.2.2. Stem Cell Therapies
8.3. Gene Therapies
8.3.1. Non Viral
8.3.2. Viral Vector
8.4. Monoclonal Antibodies
8.5. Recombinant Proteins
8.5.1. Enzymes
8.5.2. Growth Factors
8.5.3. Insulin
8.6. Vaccines
8.6.1. Conventional Vaccines
8.6.2. Mrna Vaccines
9. Continuous Bioprocessing Market, by Process Stage
9.1. Introduction
9.2. Downstream Bioprocessing
9.2.1. Continuous Chromatography
9.2.2. Continuous Extraction
9.2.3. Continuous Filtration
9.3. Upstream Bioprocessing
9.3.1. Continuous Cell Culture
9.3.2. Perfusion Culture
10. Continuous Bioprocessing Market, by Technology
10.1. Introduction
10.2. Continuous Chromatography
10.3. Continuous Filtration
10.4. Perfusion Systems
10.5. Single Use Systems
11. Continuous Bioprocessing Market, by Bioreactor Type
11.1. Introduction
11.2. Single Use Bioreactors
11.3. Stainless Steel Bioreactors
12. Continuous Bioprocessing Market, by End User
12.1. Introduction
12.2. Biotechnology Companies
12.2.1. Large Biotech Firms
12.2.2. Small Biotech Firms
12.3. CDMOS
12.3.1. Large Cdmos
12.3.2. Small Cdmos
12.4. Pharmaceutical Companies
12.4.1. Big Pharma Companies
12.4.2. Mid Tier Pharma
12.5. Research Institutes
13. Continuous Bioprocessing Market, by Scale Of Production
13.1. Introduction
13.2. Commercial Scale
13.2.1. Large Commercial Plants
13.2.2. Medium Commercial Plants
13.2.3. Small Commercial Facilities
13.3. Laboratory Scale
13.3.1. Lab Reactors 50-200L
13.3.2. Lab Reactors < 50L
13.4. Pilot Scale
13.4.1. Pilot Plants 200-500L
13.4.2. Pilot Plants < 200L
13.4.3. Pilot Plants >500L
14. Americas Continuous Bioprocessing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Continuous Bioprocessing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Continuous Bioprocessing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Danaher Corporation
17.3.3. Merck KGaA
17.3.4. Sartorius AG
17.3.5. Lonza Group AG
17.3.6. FUJIFILM Diosynth Biotechnologies
17.3.7. Repligen Corporation
17.3.8. Novasep Holding SAS
17.3.9. Applikon Biotechnology B.V.
17.3.10. Parker Hannifin Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CONTINUOUS BIOPROCESSING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CONTINUOUS BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CONTINUOUS BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CONTINUOUS BIOPROCESSING MARKET: RESEARCHAI
FIGURE 28. CONTINUOUS BIOPROCESSING MARKET: RESEARCHSTATISTICS
FIGURE 29. CONTINUOUS BIOPROCESSING MARKET: RESEARCHCONTACTS
FIGURE 30. CONTINUOUS BIOPROCESSING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CONTINUOUS BIOPROCESSING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY NON VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY NON VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INSULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY INSULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONVENTIONAL VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONVENTIONAL VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MRNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS EXTRACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CELL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CONTINUOUS FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PERFUSION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SINGLE USE BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY STAINLESS STEEL BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE BIOTECH FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE BIOTECH FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL BIOTECH FIRMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL BIOTECH FIRMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE CDMOS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE CDMOS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL CDMOS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL CDMOS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIG PHARMA COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIG PHARMA COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MID TIER PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MID TIER PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE COMMERCIAL PLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LARGE COMMERCIAL PLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MEDIUM COMMERCIAL PLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY MEDIUM COMMERCIAL PLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL COMMERCIAL FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY SMALL COMMERCIAL FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LAB REACTORS 50-200L, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LAB REACTORS 50-200L, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LAB REACTORS < 50L, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LAB REACTORS < 50L, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS 200-500L, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS 200-500L, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS < 200L, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS < 200L, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS >500L, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT PLANTS >500L, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS CONTINUOUS BIOPROCESSING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES CONTINUOUS BIOPROCESSING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 217. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 218. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 219. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 220. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 221. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 222. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 223. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 224. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 225. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 226. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 227. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 228. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 229. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 230. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 231. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 232. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 233. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2024 (USD MILLION)
TABLE 236. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2025-2030 (USD MILLION)
TABLE 237. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 240. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 241. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2024 (USD MILLION)
TABLE 242. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2025-2030 (USD MILLION)
TABLE 243. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 244. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 245. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2024 (USD MILLION)
TABLE 246. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2025-2030 (USD MILLION)
TABLE 247. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 248. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 249. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 250. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 251. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2024 (USD MILLION)
TABLE 252. CANADA CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2025-2030 (USD MILLION)
TABLE 253. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 254. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 255. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 256. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 257. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 258. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 259. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 262. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 263. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 264. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 265. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 266. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 267. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 268. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 269. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2024 (USD MILLION)
TABLE 272. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2025-2030 (USD MILLION)
TABLE 273. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 276. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 277. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2024 (USD MILLION)
TABLE 278. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2025-2030 (USD MILLION)
TABLE 279. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 280. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 281. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2018-2024 (USD MILLION)
TABLE 282. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY SCALE OF PRODUCTION, 2025-2030 (USD MILLION)
TABLE 283. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2018-2024 (USD MILLION)
TABLE 284. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY COMMERCIAL SCALE, 2025-2030 (USD MILLION)
TABLE 285. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2018-2024 (USD MILLION)
TABLE 286. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY LABORATORY SCALE, 2025-2030 (USD MILLION)
TABLE 287. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2018-2024 (USD MILLION)
TABLE 288. MEXICO CONTINUOUS BIOPROCESSING MARKET SIZE, BY PILOT SCALE, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY DOWNSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY UPSTREAM BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOREACTOR TYPE, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, BY CDMOS, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL CONTINUOUS BIOPROCESSING MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Sartorius AG
  • Lonza Group AG
  • FUJIFILM Diosynth Biotechnologies
  • Repligen Corporation
  • Novasep Holding SAS
  • Applikon Biotechnology B.V.
  • Parker Hannifin Corporation

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 343.95 Million
Forecasted Market Value ( USD ) by 2030 $ 904.2 Million
Compound Annual Growth Rate21.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Upstream Bioprocessing Market by Product (Accessories And Consumables, Bioreactors, Media And Reagents), Technology (Airlift Bioreactors, Fixed-Bed Bioreactors, Single-Use Bioreactors), Application, End User, Scale, Cell Type - Global Forecast 2025-2030 - Product Image

Upstream Bioprocessing Market by Product (Accessories And Consumables, Bioreactors, Media And Reagents), Technology (Airlift Bioreactors, Fixed-Bed Bioreactors, Single-Use Bioreactors), Application, End User, Scale, Cell Type - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Continuous Bioprocessing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Reagents), By Application (Monoclonal Antibodies, Vaccines), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Continuous Bioprocessing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Reagents), By Application (Monoclonal Antibodies, Vaccines), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Continuous Bioprocessing - Global Strategic Business Report - Product Image

Continuous Bioprocessing - Global Strategic Business Report

  • Report
  • 553 Pages
  • Global
From
Large and Small-scale Bioprocessing - Global Strategic Business Report - Product Image

Large and Small-scale Bioprocessing - Global Strategic Business Report

  • Report
  • 565 Pages
  • Global
From
Single-use Bioprocessing Market Size, Share & Trends Analysis Report By Product (Simple & Peripheral Elements, Apparatus & Plants), By Workflow (Upstream, Downstream), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Single-use Bioprocessing Market Size, Share & Trends Analysis Report By Product (Simple & Peripheral Elements, Apparatus & Plants), By Workflow (Upstream, Downstream), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From

About the Continuous Bioprocessing Market

Continuous bioprocessing is a biotechnology-based approach to the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. It involves the use of continuous manufacturing techniques, such as continuous cell culture, continuous chromatography, and continuous purification, to produce biopharmaceuticals in a more efficient and cost-effective manner than traditional batch-based processes. This approach also allows for greater control over the production process, resulting in higher quality products. Continuous bioprocessing has become increasingly popular in recent years, as it offers a number of advantages over traditional batch-based processes. These include improved process control, increased product yield, reduced production costs, and shorter production times. Some companies in the continuous bioprocessing market include Merck KGaA, Novartis, Pfizer, Sanofi, and Lonza. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.